Endocan is a soluble proteoglycan, secreted by human vascular endothelial cells. Endocan is a marker for vascular pathologies and an important mediator of angiogenesis, strongly associated with inflammation, vascular endothelial dysfunction, and atherosclerosis. The relationship between coronary artery ectasia (CAE) and endocan has not been evaluated. We aimed to investigate this association. Fifty-four patients with isolated CAE without coronary stenosis and 30 controls with normal coronary angiogram were included in this study. Endocan plasma concentrations were measured using an enzyme-linked immunosorbent assay. Patients with isolated CAE had significantly higher levels of endocan compared to the controls (18.9 ± 7.3 vs 15.6 ± 3.6 ng/mL; P = .007). There was a significant correlation between endocan levels and severity of isolated CAE according to the Markis classification (r = −.593, P < .001). Plasma endocan levels may reflect the presence and severity of isolated CAE, suggesting that endocan may be involved in pathogenesis of isolated CAE.
SarrazinSAdamELyonM. Endocan or endothelial cell specific molecule-1(ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta. 2006;1765(1):25–37.
2.
BaltaIBaltaSKoryurekOM. Serum endocan levels as a marker of disease activity in patients with Behçet disease. J Am Acad Dermatol. 2014;70(2):291–296.
3.
BaltaIBaltaSDemirkolS. Elevated serum levels of endocan in patients with psoriasis vulgaris: Correlations with cardiovascular risk and activity of disease. Br J Dermatol. 2013;169(5):1066–1070.
4.
KoseMEmetSAkpinarTS. Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study. Angiology. 2015;66(8):727–731.
5.
LeeWKuSKKimSWBaeJS. Endocan elicits severe vascular inflammatory responses in vitro and in vivo. J Cell Physiol. 2014;229(5):620–630.
6.
LuJXiangGLiuMMeiWXiangLDongJ. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Atherosclerosis. 2015;243(2):438–448.
7.
RoudnickyFPoyetCWildP. Endocan is up regulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res. 2013;73(3):1097–1106.
8.
SwantonRHThomasMLColtartDJJenkinsBSWeb-PeploMMWilliamBT. Coronary artery ectasia a variant of occlusive coronary arteriosclerosis. Br Heart J. 1978;40(4):393–400.
9.
PohlUBusseR. Endothelium-dependent modulation of vascular tone and platelet function. Eur Heart J. 1990;11(suppl b):35–42.
10.
KrugerDStierleUHerrmannGSimonRSheikhzadehA. Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms (“dilated coronopathy”). J Am Coll Cardiol. 1999;34(5):1461–1470.
11.
SezginATSigirciABarutcuI. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis. 2003;14(2):155–161.
12.
DemopoulosVPOlympiosCDFakiolasCN. The natural history of aneurismal coronary artery disease. Heart. 1997;78(2):136–141.
13.
PapadakisMCLeontiadisEManginasA. Frequency of coronary artery ectasia in patients undergoing surgery for ascending aortic aneurysms. Am J Cardiol. 2004;94(11):1433–1435.
14.
CockcroftDWGaultMH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
15.
MarkisJEJoffeCDCohnPFFeenDJHermanMVGorlinR. Clinical significance of coronary arterial ectasia. Am J Cardiol. 1976;37(2):217–222.
CelikSErdoğanTKasapH. Carotid intima-media thickness in patients with isolated coronary artery ectasia. Atherosclerosis. 2007;190(2):385–387.
18.
AntoniadisAPChatzizisisYSGiannoglouGD. Pathogenetic mechanisms of coronary ectasia. Int J Cardiol. 2008;130(3):335–343.
19.
BeckmanJSKoppenolWH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 1996;271(5 pt 1):c1424–c1437.
20.
PaikDCRameyWGDillonJTilsonnMD. The nitrite/elastin reaction: implication for in vivo degenerative effects. Connect Tissue Res. 1997;36(3):241–251.
21.
EnglandJF. Herbicides and coronary artery ectasia. Med J Aust. 1981;1(3):140.
22.
LiJJHeJGNanJLHeZXZhuCGLiJ. Is systemic inflammation responsible for coronary artery ectasia?Int J Cardiol. 2008;130(2):e69–e70.
23.
BefelerBArandaJMEmbiAMullinFLEl-SherifNLazzaraR. Coronary artery aneurysms. Study of their aetiology, clinical course and effect on left ventricular function and prognosis. Am J Med. 1977;62(4):597–607.
24.
TangPHSegalAJ. Polyarteritis nodosa of infancy: fatal late complications. JAMA. 1971;217(12):1666–1670.
25.
McKusicVA. Cardiovascular aspects of Marfan’s syndrome: hereditable disorder of connective tissue. Circulation. 1995;11(3):321–332.
26.
BaltaSOzturkC. The relation between CD40 ligand and coronary artery disease. Cardiology. 2015;131(2):107–108.
27.
ShinJWHuggenbergerRDetmarM. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. Blood. 2008;112(6):2318–2326.
28.
BaltaSMikhailidisDPDemirkolSOzturkCCelikTIyisoyA. Endocan: a novel inflammatory indicator in cardiovascular disease?Atherosclerosis. 2015;243(1):339–343.
29.
RathSHar-ZahavYBattlerA. Fate of nonobstructive aneurysmatic coronary artery disease: angiographic and clinical follow-up report. Am Heart J. 1985;109(4):785–791.
30.
ScherpereelAGentinaTGrigoriuB. Overexpression of endocan induces tumor formation. Cancer Res. 2003;63(18):6084–6089.
